IL25 and colorectal cancer: In a mouse model for spontaneous colorectal cancer (CRC), the IL-25-ILC2 axis was found to be pro-tumoral (13), while inhibiting IL-25 signaling or ILC2 cells in an induced model of CRC led to an increased number of tumors (14, 15).